News & Events about Vertex Pharmaceuticals Incorporated.
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX Get Rating) Director Lloyd Carney sold 2,700 shares of the stock in a transaction that occurred on Monday, January 30th. The stock was sold at an average price of $320.52, for a total value of $865,404.00. Following the transaction, the ...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX Get Rating) Director Yuchun Lee sold 4,000 shares of Vertex Pharmaceuticals stock in a transaction dated Wednesday, January 25th. The stock was sold at an average price of $313.96, for a total transaction of $1,255,840.00. Following the ...
Thinking about trading options or stock in Tesla, STMicroelectronics, ASML Holding, Vertex Pharmaceuticals, or Exxon Mobil? Thinking about trading options or stock in Tesla, STMicroelectronics, ASML Holding, Vertex Pharmaceuticals, or Exxon Mobil? PR Newswire NEW YORK, Jan. 18, 2023 NEW YORK, Jan...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that management will present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 at 11:15 a.m. ET/8:15 a.m. PT. A live webcast of management's remarks will be available through the Vertex website...
Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX Get Rating) have been given a consensus recommendation of Moderate Buy by the twenty-two research firms that are presently covering the stock, MarketBeat reports. Four analysts have rated the stock with a hold rating, ten have given a buy ...